Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacs
- 1 June 1990
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 75 (2) , 278-281
- https://doi.org/10.1111/j.1365-2141.1990.tb02663.x
Abstract
Factor VIII concentrate inhibits T-cell function in vitro and in vivo. The mechanisms underlying this phenomenon were investigated. Factor VIII concentrate has a direct effect on lymphocytes, uninfluenced by haemophilic monocyte dysfunction, since it inhibited lymphocyte transformation with phorbol myristate acetate, a reaction unaffected by monocyte depletion. Inhibition of lymphocytes transformation by factor VIII concentrate is not corrected by the addition of exogenous IL2, suggesting that it does not inhibit lymphocyte function by suppression of IL2 secretion alone. Factor VIII concentrate causes profound inhibition of IL2-receptor expression (CD25); with an 89% reduction in CD25-positive CD4 cells and a 50% reduction in CD25-antigen molecules per cell. CD8 lymphocytes are similarly affected. Smaller reductions in CD71 and HLA-DR expression are also observed. Down modulation of CD25-antigen may explain the reduced IL2 secretion observed by others, and may be an important cause of immunodeficiency in HIV-seronegative haemophiliacs.This publication has 15 references indexed in Scilit:
- Factor concentrates for treatment of hemophilia: which one to choose? [see comments]Blood, 1989
- Inhibition of interleuk:in‐2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacsBritish Journal of Haematology, 1989
- Change in immune response to hepatitis B in boys with haemophiliaJournal of Medical Virology, 1988
- COAGULATION FACTOR VIII CONCENTRATES AND THE MARKETPLACEThe Lancet, 1988
- A functional defect in the early phase of the immune response observed in patients with hemophilia AClinical Immunology and Immunopathology, 1986
- Unusually high incidence of tuberculosis among boys with haemophilia during an outbreak of the disease in hospital.Journal of Clinical Pathology, 1985
- A study of cell mediated and humoral immunity in haemophilia and related disordersBritish Journal of Haematology, 1985
- HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIIIThe Lancet, 1985
- ABNORMALITIES OF CIRCULATING LYMPHOCYTE SUBSETS IN HAEMOPHILIACS IN AN AIDS-FREE POPULATIONThe Lancet, 1984
- Interleukin 2Annual Review of Immunology, 1984